Cooper Companies Inc
COO.N- Latest Trade
- trading lower313.12USD
- Change
- -4.59
- % Change
1.44%Negative
- Day Range
- 311.09 - 316.64
- 52-Week Range
- 298.04 - 463.07
As of Jul 1 2022. Values delayed up to 15 minutes
- Previous Close
- 317.71
- Open
- 313.43
- Volume
- 135,099.00
- 3 Month Average Trading Volume
- 7.17
- Shares Out (Mil)
- 49.34
- Market Cap
- 15,674.70
- Forward P/E
- 24.07
- Dividend Yield
- 0.02
Key Statistics
2.1875 mean rating - 16 analysts
- P/E Excl. Extra Items (TTM)
- 16.70
- Price To Sales (TTM)
- 4.99
- Price To Book (Quarterly)
- 2.23
- Price To Cash Flow (Per Share TTM)
- 12.25
- Total Debt/Total Equity (Quarterly)
- 46.37
- Long Term Debt/Equity (Quarterly)
- 33.46
- Return On Investment (TTM)
- 10.45
- Return On Equity (TTM)
- 9.12
2021 (millions USD)
About Cooper Companies Inc
Company Information
The Cooper Companies, Inc. is a global medical device company. The Company operates through two segments: CooperVision and CooperSurgical. The CooperVision segment is engaged in developing, manufacturing, and marketing a range of products for contact lens wearers, featuring advanced materials and optics. CooperVision designs its products to solve vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues, with a collection of spherical, toric and multifocal contact lenses. The CooperSurgical segment is focused on advancing the health of women, babies, and families through a diversified portfolio of products and services including medical devices, fertility, diagnostics and contraception. CooperSurgical's products are used in medical office and surgical procedures, primarily by obstetricians/gynecologists (OB/GYN); and fertility products/equipment and genetic testing services used primarily in fertility clinics and laboratories.
Address
Ste 590, 6140 Stoneridge Mall RdPLEASANTON, CA
94588
United States
Industry
Medical Equipment & Supplies
Executive Leadership
- Robert S. Weiss
- Independent Chairman of the Board
- Albert G. White
- President, Chief Executive Officer, Director
- Brian George Andrews
- Chief Financial Officer, Executive Vice President, Treasurer
- Holly R. Sheffield
- President - CooperSurgical, Inc.
- Gerard H, Warner
- President, CooperVision, Inc
- Daniel G. McBride
- Chief Operating Officer, Executive Vice President, President - CooperVision, Inc.
- Agostino Ricupati
- Senior Vice President - Finance and Tax, Chief Accounting Officer
- Mark J. Drury
- Vice President, General Counsel, Secretary
- William A. Kozy
- Lead Independent Director
- Colleen E. Jay
- Independent Director
- Jody S. Lindell
- Independent Director
- Teresa Smith Madden
- Independent Director
- Gary S. Petersmeyer
- Independent Director
- Maria Rivas
- Independent Director
Latest News
- MarketsDocuSign, Esperion, Longeveron, Didi
Wall Street's major indexes fell in choppy trading on Friday, with the Nasdaq tumbling more than 2%, as mixed jobs data, uncertainty around the Omicron coronavirus variant and the path of the Federal Reserve's policy tightening weighed.
Markets Performance
Official Data PartnerCommodities
| Future | Last | % Change |
|---|---|---|
| Gold | 1,804.10 | -- |
| Copper | 694.15 | -- |
| Brent Crude Oil | 109.47 | 0.40%Positive |
| CBOT Soybeans | 1,669.50 | 0.33%Negative |
Stocks
| Index | Last | % Change |
|---|---|---|
| S&P 500 | 3,785.38 | 0.88%Negative |
| Euro STOXX 50 | 3,454.86 | -- |
| FTSE 100 | 7,169.28 | 1.96%Negative |
| Nikkei 225 | 26,159.53 | 0.88%Negative |
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes